# Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.

> **NCT03081832** · NA · COMPLETED · sponsor: **University Hospital, Toulouse** · enrollment: 34 (actual)

## Conditions studied

- Prader-Willi Syndrome

## Interventions

- **DRUG:** Oxytocin
- **OTHER:** Control

## Key facts

- **NCT ID:** NCT03081832
- **Lead sponsor:** University Hospital, Toulouse
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2018-05
- **Final completion:** 2018-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03081832

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03081832, "Follow-up of Prader Willi Syndrome Infants Treated by Oxytocin and Comparison With Not-treated Infants.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03081832. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*